Congenital T cell activation impairs transitional to follicular B cell maturation in humans

Computational Methods Computational Methods
Genomics Genomics
Immunology Immunology
Alex K. Shalek Alex K. Shalek
Michelle Ramseier Michelle Ramseier

Allard-Chamard et al.▾ Allard-Chamard, H., Hillier, K., Ramseier, M. L., Bertocchi, A., Kaneko, N., Premo, K., Lam, T., Yuen, G., Karpel, M., Mahajan, V. S., Tsekeri, C., Vencic, J., Crotty, R., Sharda, A., Barmettler, S., Westermann-Clark, E., Walter, J. E., Ghebremichael, M., Shalek, A. K., Farmer, J. R., Pillai, S.

bioRxiv , Volume 2024

February, 2024

Abstract

CTLA4-deficient patients exhibit profound humoral immune dysfunction, yet the basis for the B cell defect is not known. We observed a marked reduction in transitional to follicular B cell development in CTLA4-deficient patients, correlating with decreased CTLA4 function in regulatory T cells and increased mTORC1 signaling in transitional B cells. Treatment of transitional B cells with CD40L was sufficient to induce mTORC1 signaling and inhibit follicular B cell maturation in vitro. Frequent cell-cell contacts between CD40L+ T cells and naïve IgD+CD27 B cells were observed in patient lymph nodes. Follicular B cell maturation in CTLA-deficient patients was partially rescued following CTLA4 replacement therapy in vivo. We conclude that functional regulatory T cells and the containment of excessive T cell activation are required for follicular B cells to mature and attain metabolic quiescence and thus acquire a state of immunological self-tolerance.